Chat with us, powered by LiveChat
Home>Products>POCT Testing, Immunofluorescence Quantitative Analyzer>POCT Fully Immunofluorescence Quantitative Analyzer, IFA-Q-1000

POCT Fully Immunofluorescence Quantitative Analyzer, IFA-Q-1000

  1. Detection speed: 10 sec/test
  2. Time of the first result: 5-15min
  3. Sample position: 8 channel (stackable)

Share the product

Description

POCT Fully Quantitative Immunofluorescence Analyzer
Most Stable Rare Earth Material Time-Resolved
Immunofluorescence Methodology
Top Quality POCT Immunofluorescence Platform
Platform Features
Sample Types: Serum, Whole Blood, Plasma, Fingertip Blood, Urine…
Parameters:Diabetes,Kidney Function,Infection,Cardiac Function,Gastric Function…
Comprehensive
Various assays
Comprehensive sample types
Simple and Convenient
Small size, space -saved, stacked incubators
Convenient operation, no requirement for professional skills
Accuracy
Constant incubation, corruption prevention,
low coefficient variance Precise quality control, accurate results
Rapidity
Point of care testing
Instant results analysis in 10 seconds

Specifications

Subject Performance parameter
Detection speed 10 sec/test
Time of first result 5-15min
Sample position 8 channel (stackable)
LIS system Support ASTM and HL7
Size(mm) 214mm×260mm×143mm
Weight 2kg
Control Embedded integrated machine
Interface Graphical operation interface
Status monitor Real-time intelligent monitoring
Repeatability CV≤15%
Fluorescence

Rare Earth Fluorescence life-span is longer than Quantum
Fluorescence with no disruption and high accuracy

Fluorescent materials Life-span
Fluorescent rare earth 714000 ns
Quantum 20-50 ns
Nonspecific fluorescent particle 1-10 ns

Rare earth fluorescence has larger stokes shift, higher signal-to noise ratio (SNR) and higher sensitivity compared to other markers

Rare earth fluorescence has high quantum yield, high fluorescent efficiency, and wide linear range

Menu of assays

Biomarkers Abbr. Specimen Instruction for Use Expected values Measuring range
Inflammation Procalcitonin

 

PCT Serum/Whole Blood lndicate sepsis and bacterial infection <0.05 ng/mL 0.05-100 ng/mL
Full Range
C-reactive Protein
CRP Plasma/Whole Blood Low risk of cardiovascular disease Medium risk of cardiovascular disease ·High risk of cardiovascular disease Detecting conventional inflammation hs-CRP:<1.0mg/L hs-CRP:1.0-3.0mg/L hs-CRP:>3.0mg/L CRP:≤10 mg/L 0.5-200 mg/L
C-reactive Protein/Amyloid proteinase A 2-in-1 CRP/SAA Plasma/Whole Blood ·Low risk of cardiovascular disease ·Medium risk of cardiovascular disease
·High risk of cardiovascular disease Detecting conventional inflammation
hs-CRP: <10mg/L hs-CRP:1.0-3.0mg/L
hs-CRP: >3.0mg/L CRP:≤10 mg/L
0.5-200 mg/L
Immune Rheumatism 3-in-1 ASO/RF/CRP Serum/Plasma/
Whole Blood
lndicators of systemic inflammation ·To assist in the diagnosis,classification and prognosis of rheumatoid arthritis ASO:≤200 IU/mL
RF:≤20IU/mL
CRP:≤10 mg/L
ASO:50-500 IU/mL
RF:10-200 IU/mL
CRP:0.5-200 mg/L
*Anti cyclic citrullinated peptide antibody Anti-CCP Serum/Plasma/Whole Blood ·Assistant diagnostic indexe of rheumatoid arthritis s25 U/mL 25-1000 U/mL
Cardiovascular Cardiac Troponin I cTnl Serum/Plasma/Whole Blood ·Diagnose AMI,risk stratification and evaluate prognosis Value markers of non ST segment elevation MI ≤0.3 ng/mL 0.1-50 ng/mL
Creatine Kinase-MB CK-MB Serum/Plasma/Whole Blood ·Negative exclusion of early AMI; Detection of recurrence and thrombolytic therapy ≤5 ng/mL 1-100 ng/mL
Myoglobin MYO Serum/Plasma/Whole Blood Early diagnosis of AMI s70 ng/mL 5-500 ng/mL
Myocardial Infarction(MI) 3-in-1 cTnl/MYO/
CK-MB
Serum/Plasma/Whole Blood Same as above 3 markers cTnl:≤03ng/mL MYO=70 ng/mL CK-MB:≤5ng/mL cTnl:01-50 ng/mL MYO:5-500 ng/mL CK-MB:1-100 ng/mL
D-Dimer(D-Dimer) D-Dimer Plasma/Whole Blood Exclusion and diagnosis of venous thromboembolism ≤0.5 mg/L 0.1-10 mg/L
N-terminal B-type natriuretic peptide NT-proBNP Serum/Plasma/Whole Blood Diagnosis heart failure,risk stratification and prognostic evaluation ≤300 pg/mL 50-35000 pg/mL
*Lipoprotein-Associated Phospholipase A2 Lp-PLA2 Serum/Plasma/Whole Blood lndicating the stability of atherosclerotic plaque ·Predicting the risk of coronary heart disease and stroke s200ng/mL 20-1000 ng/mL
*cTnl/NT-proBNP/D-Dimer 3-in-1 cTnl/
NT-proBNP/
D-Dimer
Plasma/Whole Blood Same as above 3 markers ctnl:s03ng/mL NT-proBNP:≤300 pg/mL D-Dimer:≤0.5 mg/L cTnl:01-50 ng/mL NT-proBNP:100-20000 pg/mL D-Dimer:0.1-10 mg/L

    Contact Us Now!

    We will usually contact you within 24 hours. You could also call us (+86-531-88982330) during working hours ( 8:30 am to 5:45 pm UTC+8 Mon.~Sat. ) or use the website live chat to get prompt reply.

    Contact Info

    17th floor, Mingsheng Building, Xinluo Street, Jinan

    Phone: +86-531-88982330

    Fax: +86-531-88983691

    Web: www.bioevopeak.com

    Go to Top